Home › Metastatic Cancer › Massachusetts › Boston

Pag-aaral pangklinika para sa Metastatic Cancer sa Boston, MA

Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Boston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07193511

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Nagre-recruitPhase 2

Tufts Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Lahat ng edad · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05372614

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

Dana Farber Cancer Institute, Boston

Edad 19 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06586957

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Insitute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06625775

A Study of ASP3082 in Adults With Advanced Solid Tumors

Nagre-recruitPhase 1

Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT05382559

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Nagre-recruitPhase 2/3

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06943755

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Nagre-recruitPhase 3

Brigham and Women's Hospital (BWH), Boston
Dana-Farber Cancer Institute (DFCI), Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07222800

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute., Boston

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

Nagre-recruitPhase 1/2

Mass General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT05118789

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Nagre-recruitPhase 1

Mass General Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06915753

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06302621

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Nagre-recruitPhase 3

Mass General Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Nagre-recruitPhase 1/2

Massachusetts General Hospital - Main Campus, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07629960

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Nagre-recruitPhase 1/2

Brigham and Women's Hospital, Boston
Dana Farber/Mass General Brigham Cancer Care, Inc, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07227415

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06561685

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Nagre-recruitPhase 3

Boston Medical Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581

Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT04585958

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Nagre-recruitPhase 2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT06311214

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, Boston

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07038343

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 18 pataas · Kababaihan · Na-update Set 3, 2026 · NCT04802759

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital (MG), Boston

Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06983743

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07029399

Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT05687136

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT05614739

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05919264

Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes

Nagre-recruitPhase 1

Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05687110

Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT05372640

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT05533697

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT07137416

A Study of PYX-201 in Advanced Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT05720117

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Nagre-recruitPhase 1

Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347

A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Exelixis Clinical Site #10, Boston
Exelixis Clinical Site #11, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 24, 2026 · NCT06952010

A Study of LY4175408 in Participants With Advanced Cancer

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT07046923

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07284186

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

Nagre-recruitPhase 1

Research Site, Boston
Research Site, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 10, 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT06917079

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 12 pataas · Lahat ng kasarian · Na-update May 27, 2026 · NCT05384626

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Nagre-recruitPhase 3

Massachusetts General Hospital Cancer Center, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 18, 2026 · NCT06757634

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Nagre-recruitPhase 1/2

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 15, 2026 · NCT05379985

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

Nagre-recruitPhase 2

I-Mab Site 1002, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT07432295

Remote Monitoring and Symptom Management Digital Application

Nagre-recruit

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 28, 2026 · NCT07553572

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Nagre-recruitPhase 1/2

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT07020221

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

Nagre-recruitPhase 2/3

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06947928

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Nagre-recruitPhase 3

Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT06064877

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

Nagre-recruitPhase 2/3

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston

Edad 18 pataas · Kalalakihan · Na-update Abr 8, 2026 · NCT04787744

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Nagre-recruitPhase 2/3

Massachusetts General Hospital, Boston

Lahat ng edad · Lahat ng kasarian · Na-update Abr 2, 2026 · NCT06581406

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 1, 2026 · NCT05735080

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Nagre-recruitPhase 1/2

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT06244771

Venetoclax Basket Trial for High Risk Hematologic Malignancies

Nagre-recruitPhase 1

Dana-Farber Cancer Institute, Boston

Edad 1 hanggang 40 · Lahat ng kasarian · Na-update Mar 12, 2026 · NCT05292664

Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver

Nagre-recruit

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 11, 2026 · NCT07364474

Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 6, 2026 · NCT06171750

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Mass General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 5, 2026 · NCT04900818

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Nagre-recruitPhase 1

Massachusetts General Hospital, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 25, 2026 · NCT06521554

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Nagre-recruitPhase 3

Dana-Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT06127407

IlluminOss Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pelvis Fractures

Nagre-recruitObservasyonal na pag-aaral

Massachusetts General Hospital, Boston

Edad 21 pataas · Lahat ng kasarian · Na-update Ene 16, 2026 · NCT04842266

Comprehensive Outcomes for After Cancer Health

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Dana Farber Cancer Institute, Boston

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2024 · NCT05349227

Pag-aaral para sa Metastatic Cancer sa ibang lungsod

Iba pang pag-aaral sa Boston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.